Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density

Journal of Clinical Oncology

Volumn 15, Issue 10, 1997, Pages 3201-3207

  Persson, Ingemar ^a   Thurfjell, Erik ^a   Holmberg, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIENESTROL; ESTRADIOL; ESTRADIOL VALERATE; ESTRIOL; ESTROGEN; GESTAGEN; LEVONORGESTREL; NORETHISTERONE ACETATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMAGE QUALITY; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RELIABILITY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030921829     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.10.3201     Document Type: Article

References (30)

1. Wiklund I, Karlberg J, Mattsson L-Å: Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. Am J Obstet Gynecol 168:824-830, 1993
2. Stampfer MJ, Colditz GA: Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63, 1991
3. Cummings SR, Kelsey JL, Nevitt MC, et al: Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7:178-208, 1985
4. Hulka BS, Liu ET, Lininger RA: Steroid hormones and risk of breast cancer. Cancer 74:1111-1124, 1994
5. Brinton LA, Schairer C: Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 15:66-79, 1993
6. Schairer C, Byrne C, Keyl PM, et al: Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer. Cancer Causes Control 5:491-500, 1994
7. Stanford JL, Thomas DB: Exogenous progestins and breast cancer. Epidemiol Rev 15:98-107, 1993
8. Colditz GA, Hankinson SE, Hunter DJ, et al: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589-1593, 1995
9. Tabár L, Fagerberg CJG, Gad A, et al: Reduction in mortality from breast cancer after mass screening with mammography: Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829-832, 1985
10. Berkowitz JE, Gatewood OMB, Goldblum LE, et al: Hormonal replacement therapy: Mammographic manifestations. Radiology 174:199-201, 1990
11. Kaufman Z, Garstin WIH, Rayes R, et al: The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 43:389-392, 1991
12. Bergkvist L, Tabár L, Adami H-O, et al: Mammographic parenchymal pattern in women receiving non-contraceptive estrogen treatment. Am J Epidemiol 130:503-510, 1989
13. Stomper PC, Van Voorhis BJ, Ravnikar VA, et al: Mammographic changes associated with postmenopausal hormone replacement therapy: A longitudinal study. Radiology 174:487-490, 1990
14. McNicholas MMJ, Heneghan JP, Milner MH, et al: Pain and increased mammographic density in women receiving hormone replacement therapy. Am J Roentgenol 163:311-315, 1994
15. Laya MB, Gallagher JC, Schreiman JS, et al: Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196:433-437, 1995
16. Cyrlak D, Wong CH: Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. Am J Roentgenol 161:1177-1183, 1993
17. Feig SA: Hormonal reduction of mammographic densities: Potential effects on breast cancer risk and performance of diagnostic and screening mammography. J Natl Cancer Inst 86:408-409, 1994
18. Jackson VP, Hendrick RE, Feig SA, et al: Imaging of the radiographically dense breast. Radiology 188:297-301, 1993
19. Ma L, Fishell E, Wright B, et al: Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 84:781-785, 1992
20. Laya MB, Larson EB, Taplin SH, et al: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 88:643-649, 1996
21. Thurfjell EL, Lindgren JAÅ: Population-based mammography screening in Swedish clinical practice: Prevalence and incidence screening in Uppsala county. Radiology 193:351-357, 1994
22. Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37:2486-2492, 1976
23. Wolfe JN: Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 126:1130-1139, 1976
24. Wolfe JN, Albert S, Belle S, et al: Breast parenchymal patterns; Analyses of 332 incident breast carcinomas. Am J Roentgenol 138:113-118, 1987
25. Peck DR, Lowman RM: Estrogen and the postmenopausal breast: Mammographic considerations. JAMA 240:1733-1735, 1976
26. Meyer JE, Frenna TH, Polger M, et al: Enlarging occult fibroadenomas. Radiology 183:639-641, 1992
27. Pike MC, Spicer DV, Dahmoush L, et al: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17-35, 1993
28. Persson I, Yuen J, Bergkvist L, et al: Combined oestrogen-progestogen replacement and breast cancer risk. Lancet 340:1044, 1992
29. Bergkvist L, Adami H-O, Persson I, et al: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293-297, 1989
30. Black WC, Fletcher SW: Effects of estrogen on screening mammography: Another complexity. J Natl Cancer Inst 88:627-628, 1996